BIOX Latest Quarter's Earnings
Announce Date 11/12/2025
EPS Normalized Actual $-0.1183 (Miss by $-0.1883)
EPS GAAP Actual $-0.1183 (Miss by $-0.1883)
Revenue Actual $0.077436B
Revenue Surprise Beat by $77.436M
Upcoming Quarter's Earnings
Announce Date 03/30/2026 (Pre-Market)
EPS Normalized Estimate $0.01
EPS GAAP Estimate $0.01
Revenue Estimate $0.105B
Annual EPS Estimate
Fiscal Period Ending EPS Estimate Forward PE Low High # of Analysts
Jun 2029 1.55 0.37 1.53153 1.57214 0
Jun 2028 2.32 0.25 2.23761 2.4179 0
Quarterly EPS History
Period EPS Beat / Miss Revenue YoY Beat / Miss
FQ3 2025 (Sep 2025) -0.12 -0.22 0.077436B -19.58% -52.56M
FQ2 2025 (Jun 2025) -0.7 -0.7 0.0744B -67.07% 74.4M
FQ1 2025 (Mar 2025) -0.0207 0.0018 0.059596B -40.95% -29.16M
FQ4 2024 (Dec 2024) 0.0016 -0.1859 0.1068B -31.37% -45.65M
FQ3 2024 (Sep 2024) -0.0874 -1.62881 0.0926B -25.92% -142.98M
FQ2 2024 (Jun 2024) -0.0255 -0.0255 0.1243B 100% 124.3M
FQ1 2024 (Mar 2024) 0.15 -1.42645 0.084B 100% -99.23M
FQ4 2023 (Dec 2023) 0.0016 -0.0984 0.1403B 100% 22.43M
Quarterly Estimates Summary

FQ4 Announce Date

03/30/2026 (Pre-Market)

Consensus EPS Estimates

0.01

Consensus Revenue Estimates

0.105B

Consensus EPS Estimates
Fiscal Period Ending EPS Estimate YoY Growth(%) Low High # of Analysts
FQ1 2026 (Mar 2026) 0.01 307 0.01 0.01 1
Consensus Revenue Estimates
Fiscal Period Ending Revenue Estimate YoY Growth(%) Low High # of Analysts
FQ1 2026 (Mar 2026) 0.11B 43.24 0.11B 0.11B 1
Quarterly Estimates Revisions

EPS # of Up Revisions

4

EPS # of Down Revisions

4

Revenue # of Up Revisions

6

Revenue # of Down Revisions

3

Consensus EPS Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Consensus Revenue Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Earnings Surprise Summary

EPS # of Beats

1

EPS # of Misses

7

EPS # of in-lines

0

Revenue # of Beats

3

Revenue # of Misses

5

Revenue # of in-lines

0

Earnings Surprise (EPS) - Actual vs Consensus
Earnings Date EPS Estimate EPS Actual Surprise Surprise %
FQ3 2025 (Sep 2025) 0.1 -0.12 -0.22 183.33%
FQ2 2025 (Jun 2025) -0.7 -0.7 100%
FQ1 2025 (Mar 2025) -0.0225 -0.0207 0.0018 -8.7%
FQ4 2024 (Dec 2024) 0.1875 0.0016 -0.1859 -11618.75%
FQ3 2024 (Sep 2024) 1.54141 -0.0874 -1.62881 1863.63%
FQ2 2024 (Jun 2024) -0.0255 -0.0255 100%
FQ1 2024 (Mar 2024) 1.57645 0.15 -1.42645 -950.97%
FQ4 2023 (Dec 2023) 0.1 0.0016 -0.0984 -6150%
Revenue Surprise - Actual vs Consensus
Earnings Date Revenue Estimate Revenue Actual Surprise Surprise %
FQ3 2025 (Sep 2025) $0.13B $0.08B $-52.56M -67.88%
FQ2 2025 (Jun 2025) $0B $0.07B $74.4M 100%
FQ1 2025 (Mar 2025) $0.09B $0.06B $-29.16M -48.93%
FQ4 2024 (Dec 2024) $0.15B $0.11B $-45.65M -42.74%
FQ3 2024 (Sep 2024) $0.24B $0.09B $-142.98M -154.4%
FQ2 2024 (Jun 2024) $0B $0.12B $124.3M 100%
FQ1 2024 (Mar 2024) $0.18B $0.08B $-99.23M -118.13%
FQ4 2023 (Dec 2023) $0.12B $0.14B $22.43M 15.99%
Unlock